Sensor chip selection is a critical feature of every Surface Plasmon Resonance (SPR) assay. From initial design and development to data acquisition and analysis, overall data integrity is influenced by initial sensor chip selection.
Discover the most popular diagnostic news this month
New Products, Articles and Application Notes
Waters and Wyatt Technology join forces to help accelerate the therapeutic pipeline and allow biotherapeutics to reach patients quicker
Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field
Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays
Find out how Swiss company leadXpro is collaborating with a leading interferometry technology provider to investigate drug binding affinity and kinetics
A versatile Stomacher® designed for the BAM testing procedure as well as large volume blending and extraction.
The Company will also be providing an update to its distributors and other customers on July 26 at 11 am CT
The Dianthus instrument includes breakthrough Spectral Shift technology for affinity-based screenings in drug discovery
OncoSpan range expanded to include FFPE and cfDNA formats to mimic solid tumors and liquid biopsy samples, respectively
Differentiate human pluripotent stem cells to muscle myotubes
How customer feedback shaped the NuWind multi-application centrifuge
For simultaneous whole genome sequencing and whole transcriptome sequencing library preparation from a single sample
Industry experts discuss the role of artificial intelligence in the fight against COVID-19, the lessons learned and its future promise in healthcare
Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).
Discover how researchers at Weill Cornell Medical College are using immunoproteomics to identify biomarkers that help better understand and manage diabetic infections
